Operating Expenses

R&D

Ciena R&D decreased by 3.3% to $221.46M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 14.9%, from $192.66M to $221.46M. Over 4 years (FY 2021 to FY 2025), R&D shows an upward trend with a 12.1% CAGR.

Analysis

StatementIncome Statement
SectionOperating Expenses
CategoryGrowth
SignalContext dependent
VolatilityModerate
First reportedQ1 2014
Last reportedQ1 2026Mar 5, 2026

How to read this metric

Higher spending signals a commitment to innovation and future product launches, whereas significant cuts may indicate a shift toward short-term profitability.

Detailed definition

Research and development expenses represent the costs incurred to discover new products, improve existing technologies,...

Peer comparison

Highly comparable across pharmaceutical and medical device peers, where R&D intensity is a key metric for long-term valuation.

Metric ID: research_and_development

Historical Data

20 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value$110.25M$146.23M$147.45M$148.41M$159.32M$150.03M$166.90M$181.73M$189.99M$189.39M$189.44M$187.27M$195.38M$188.89M$195.96M$192.66M$214.87M$211.90M$228.90M$221.46M
QoQ Change+32.6%+0.8%+0.6%+7.4%-5.8%+11.2%+8.9%+4.5%-0.3%+0.0%-1.1%+4.3%-3.3%+3.7%-1.7%+11.5%-1.4%+8.0%-3.3%
YoY Change+44.5%+2.6%+13.2%+22.5%+19.2%+26.2%+13.5%+3.0%+2.8%-0.3%+3.4%+2.9%+10.0%+12.2%+16.8%+14.9%
Range$110.25M$228.90M
CAGR+15.8%
Avg YoY Growth+13.0%
Median YoY Growth+12.7%

Frequently Asked Questions

What is Ciena's r&d?
Ciena (CIEN) reported r&d of $221.46M in Q4 2025.
How has Ciena's r&d changed year-over-year?
Ciena's r&d increased by 14.9% year-over-year, from $192.66M to $221.46M.
What is the long-term trend for Ciena's r&d?
Over 4 years (2021 to 2025), Ciena's r&d has grown at a 12.1% compound annual growth rate (CAGR), from $536.67M to $848.33M.
What does r&d mean?
The money spent on creating new products or improving existing ones to drive future growth.